When comparing the transcription level of Bmi-1 in the different clinical groups, i.e. breast cancer, tissue taken in the vicinity of the tumor, fibroadenomas and breast tissue from non cancer controls, statistically significant differences were observed between the groups (table 3). Here, BMI1 is linked to neoplasm.